## Background: The number of patients aged > or =75 years who present with a stage i nonsmall cell lung cancer (nsclc) is increasing. elderly patients often have significant comorbidity and may be unfit for surgery. furthermore, surgery in the elderly is associated with increased mortality and morb
Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer
β Scribed by John M. Varlotto; Abram Recht; Margaret Nikolov; John C. Flickinger; Malcolm M. DeCamp
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 383 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: The objective of this study was to identify the factors associated with improved outcome after treatment for stage III nonsmall cell lung cancer (NSCLC). ## METHODS: A retrospective review of stage III NSCLC patients treated at who were treated at the DanaβFarber Cance
The purpose of this study was to evaluate the outcome of treatment for patients with newly diagnosed nonsmall-cell lung cancer (NSCLC) with an isolated, single, synchronous brain metastasis. A retrospective review was performed evaluating any patient diagnosed between 1982 and 1996 at the Cleveland
## Abstract The primary objective of this study is to identify prognostic siteβspecific epigenetic changes in surgically treated Stage I and II nonsmall cell lung cancer (NSCLC) patients by quantifying methylation levels at multiple CpG sites within each gene promoter. Paraffinβembedded tumors from